EODData

MEMBERSHIP REGISTER LOG IN

NASDAQ, ROIV: Roivant Sciences Ltd

06 May 26 15:59
LAST:

28.81

CHANGE:
 0.50		OPEN:
28.47		HIGH:
28.86		ASK:
0.00		VOLUME:
2.63M
CHG(%):
1.77		PREV:
28.32		LOW:
28.42		BID:
0.00		 

CHART

RECENT END OF DAY PRICES

DateOpenHighLowCloseVolume
06 May 2628.4728.8528.4228.823.69M
05 May 2628.6429.0028.0628.322.65M
04 May 2628.4828.4827.5228.365.3M
01 May 2628.7828.9327.8327.834.23M
30 Apr 2627.9328.7127.8928.537.01M
29 Apr 2627.7427.9427.4527.524.37M
28 Apr 2628.0228.5827.7227.774.54M
27 Apr 2627.4628.3727.3027.855.01M
24 Apr 2628.2428.3227.0627.415.62M
23 Apr 2629.2529.4127.9228.147.6M

PROFILE

Name:Roivant Sciences Ltd
About:Roivant Sciences Ltd., a clinical-stage biopharmaceutical company, focuses on the discovery, development, and commercialization of medicines and technologies. Its clinical product candidates include IMVT-1402, a fully human monoclonal antibody that targets the neonatal fragment crystallizable receptor for the treatment of graves' disease, difficult-to-treat rheumatoid arthritis, sjögren's disease, myasthenia gravis, chronic inflammatory demyelinating polyneuropathy, and cutaneous lupus erythematosus indications; batoclimab, a fully human monoclonal antibody for the treatment of thyroid eye disease; and brepocitinib, a potent small molecule inhibitor of TYK2 and JAK1 in development for the treatment of dermatomyositis, non-infectious uveitis, cutaneous sarcoidosis, and other immune-mediated diseases. The company's lead program consists of mosliciguat, an inhaled sGC activator for the treatment of pulmonary hypertension associated with interstitial lung disease and other cardiopulmonary diseases. In addition, the company offers delivery platforms comprising lipid nanoparticle (LNP) platform and ligand conjugate platform. Roivant Sciences Ltd. was founded in 2014 and is based in London, United Kingdom.
Sector:Healthcare
Industry:Biotechnology
Address:11-12 St. James's Square, London, United Kingdom, SW1Y 4LB
Website:https://roivant.com
CUSIP:G76279101
CIK:0001635088
ISIN:BMG762791017
FIGI:BBG007STW2B8
LEI:549300DL466NY5J6U724

API SERVICE  NEW

Have you tried our new API Service yet?

For more information, visit our API page.

You can get your ApiKey over HERE.

If you're ready to get going, then jump over to:
https://api.eoddata.com

SYMBOL HISTORY

   Add to Watchlist

DOWNLOAD DATA

Download stock quote history quickly and easily in a variety of formats to suit your needs.

  Download

FUNDAMENTALS

Trailing P/E:1.95 
Forward P/E:-26.93 
PEG Ratio:-0.01 
Price to Sales:587.56 
Price to Book:4.62 
Profit Margin:0.97 
Operating Margin:-128.40 
Return on Assets:-0.13 
Return on Equity:-0.18 
EPS Ratio:-1.17 
Revenue:23.23M 
Shares:715.7M 
Market Cap:20.619B 

TECHNICAL INDICATORS

MA5:28.371.5%
MA10:28.062.7%
MA20:28.560.9%
MA50:28.331.7%
MA100:25.8811.3%
MA200:20.8838.0%
STO9:88.68 
STO14:50.90
RSI14:47.37
WPR14:-41.74
MTM14:-1.01
ROC14:-0.03 
ATR:0.95 
Week High:29.000.7%
Week Low:27.455.0%
Month High:30.184.8%
Month Low:27.0638.0%
Year High:30.335.3%
Year Low:10.58172.3%
Volatility:17.07